ArticleInternational journal of molecular sciences2023

Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells.

Christian Schrenk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.